Table 1 Cumulative reduction in cases (percent) of HPV 6/11/16/18 disease by HPV vaccination over time in Estonia, model estimates
Over 25 years | Over 50 years | Over 100 years | |
|---|---|---|---|
HPV16/18-related cervical cancer | 31 (2%) | 654 (17%) | 4103 (52%) |
HPV16/18-related CIN2/3 | 1390 (12%) | 9541 (40%) | 32508 (68%) |
HPV16/18-related CIN1 | 554 (15%) | 3391 (45%) | 10760 (71%) |
HPV6/11-related CIN1 | 271 (32%) | 1016 (61%) | 2591 (77%) |
HPV6/11-related genital warts (female) | 6663 (36%) | 23246 (63%) | 58035 (79%) |
HPV6/11-related genital warts (male) | 2092 (28%) | 7873 (53%) | 20047 (67%) |